The whole slide should be examined carefully to look for recognizable HSIL to avoid unnecessary ASC-H reports.
ASC-H is reported when features of HSIL are uncertain after consideration of all the conditions discussed above as potential false negatives and false positives.
It is easy to see how Figures 10.1 (b), 10.2 (a-b) and 10.3 (a-c) could have been reported as ASC-H if these cells were representative of the most abnormal cells on the slide. Indeed, some of them were reported as ASC-H, which may avoid false negative reports in difficult cases.
Equally, in some examples of immature squamous metaplasia, tubal metaplasia and lower uterine segment sampling it may be difficult in practice to avoid an ASC-US or ASC-H report – as in Figures 10.5 (c-d), 10.6 (b), 10.8 (b) and 10.9 (b).
Colposcopy and slide review of cytology and histology can avoid unnecessary treatment in potential false positive cytology cases.
Monitoring HSIL rates for laboratories and individuals can be used as a method of quality control.
Atypical glandular cells (AGC)
AGC presents a two-fold problem in the context of false negatives and false positives:
Distinguishing benign or metaplastic processes from neoplastic glandular cells as in Figure 10.11 (a-b).
Distinguishing reactive glandular cells from HSIL as in Figure 10.5 (c).
Classical features of AIS must be distinguished from reactive endocervical cells, tubal metaplasia and TEM by attention to the chromatin pattern, palisading arrangement of cells and absence of stromal cells or cilia.
Clinico-pathological correlation and slide review before treatment is the key to avoiding over- or under-treatment of ‘difficult’ glandular abnormalities.